Evidence map›Paper›PMID 33467397›Full record

ArticleInternational journal of molecular sciences2021

Developing Tadpole

Arianna Lopez, Carolyn Shoen, Michael Cynamon, Dionysia Dimitrakopoulou, Matthieu Paiola, Martin S Pavelka, Jacques Robert

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Arianna LopezDepartment of Immunology and Microbiology, Medical Center, University of Rochester, Rochester, NY 14642, USA.ORCID 0000-0003-0019-5103
Carolyn ShoenCentral New York Research Corporation, Syracuse, NY 13210, USA.
Michael CynamonCentral New York Research Corporation, Syracuse, NY 13210, USA.
Dionysia DimitrakopoulouDepartment of Immunology and Microbiology, Medical Center, University of Rochester, Rochester, NY 14642, USA.
Matthieu PaiolaDepartment of Immunology and Microbiology, Medical Center, University of Rochester, Rochester, NY 14642, USA.ORCID 0000-0002-3536-861X
Martin S PavelkaDepartment of Immunology and Microbiology, Medical Center, University of Rochester, Rochester, NY 14642, USA.
Jacques RobertDepartment of Immunology and Microbiology, Medical Center, University of Rochester, Rochester, NY 14642, USA.ORCID 0000-0003-4380-1476
University of Rochester Medical Center · USCentral New York Research Corporation · US

Funding

A Xenopus Laevis Research Resource for ImmunologyR24AI059830 · NIAID · UNIVERSITY OF ROCHESTER · PI JACQUES Robert · 2004 to 2026
$7.7M
A Xenopus tadpole alternative model to study innate-like T cell-mediated anti-mycobacterial immunityR21AI139718 · NIAID · UNIVERSITY OF ROCHESTER · PI ROBERT, JACQUES · 2018 to 2019
$424k
Division of Integrative Organismal Systems 1456213Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases R24AI059830; R21AI139718; R21AI115527NIAID NIH HHS R21 AI139718NIAID NIH HHS R24 AI059830
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease Models, AnimalAnimalsDisease ResistanceHost-Pathogen InteractionsHumansLarvaLiverLungMiceMice, Inbred C57BLMycobacterium abscessusMycobacterium Infections, NontuberculousTime FactorsT-LymphocytesVirulenceXenopus laevisaquatic vertebratesdisseminationlarval stagemicrobial persistencemorphotypemycobacterianon-mammalian modelXenopus

Identifiers

PMID33467397
PMCPMC7829954
OpenAlexW3119655367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.